AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Drug: betaxolol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: Adrb2
UniProt: Q8K4Z4 (ADRB2_CAVPO)
Organism: Cavia porcellus
Activity: Kd = 6.98
Assay: In vitro beta-2 adrenergic receptor activity was determined by measuring inhibition of the isoproterenol induced relaxation in isolated guinea pig tracheal chains contracted with PGF2-alpha
Drug: betaxolol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: Q28044 (ADRB2_BOVIN)
Organism: Bos taurus
Activity: IC50 = 6.18
Assay: Compound was tested for inhibition of [3H]dihydroalprenolol radioligand binding to Beta-2 adrenergic receptor in calf lung membranes.
Drug: betaxolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: Adrb1
UniProt: P18090 (ADRB1_RAT)
Organism: Rattus norvegicus
Activity: Kd = 8.53
Assay: Antagonist activity at rat beta1 adrenoceptor
Drug: betaxolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: B0FL73 (B0FL73_CAVPO)
Organism: Cavia porcellus
Activity: Kd = 8.76
Assay: In vitro beta-1 adrenergic receptor activity was determined via inhibition of the positive chronotropic actions of isoproterenol in isolated guinea pig atrial preparations
Drug: betazole
Target: Histamine H2 receptor (GPCR)
Gene: HRH2
UniProt: P25021 (HRH2_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Drug: bethanechol
Target: Muscarinic acetylcholine receptor M1 (GPCR)
Gene: CHRM1
UniProt: P11229 (ACM1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4
Action type: AGONIST
Drug: bethanechol
Target: Muscarinic acetylcholine receptor M2 (GPCR)
Gene: CHRM2
UniProt: P08172 (ACM2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4
Action type: AGONIST
Drug: bethanechol
Target: Muscarinic acetylcholine receptor M3 (GPCR)
Gene: CHRM3
UniProt: P20309 (ACM3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4.2
Action type: AGONIST
Drug: bethanechol
Target: Muscarinic acetylcholine receptor M4 (GPCR)
Gene: CHRM4
UniProt: P08173 (ACM4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4
Action type: AGONIST
Drug: bethanechol
Target: Muscarinic acetylcholine receptor (GPCR)
Gene: GPM3
UniProt: Q8VH26 (Q8VH26_CAVPO)
Organism: Cavia porcellus
Activity: Kd = 4.9
Assay: Binding affinity to muscarinic M3 receptor in guinea-pig ileum
Drug: bethanechol
Target: Muscarinic receptor 2 (GPCR)
Gene: GPM2
UniProt: Q8VH27 (Q8VH27_CAVPO)
Organism: Cavia porcellus
Activity: EC50 = 6
Assay: Agonist activity at muscarinic M3 receptor in albino guinea pig ileum assessed as stimulation of electrically-induced response
Drug: betanidine
Target: Sodium-dependent noradrenaline transporter (Transporter)
Gene: SLC6A2
UniProt: P23975 (SC6A2_HUMAN)
Organism: Homo sapiens
Action type: SUBSTRATE
Drug: bevantolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Action type: ANTAGONIST
Drug: bexarotene
Target: Retinoic acid receptor alpha (Nuclear hormone receptor)
Gene: RARA
UniProt: P10276 (RARA_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.74
Assay: Selective activity towards retinoic acid receptor-alpha
Drug: bexarotene
Target: Peroxisome proliferator-activated receptor gamma (Nuclear hormone receptor)
Gene: PPARG
UniProt: P37231 (PPARG_HUMAN)
Organism: Homo sapiens
Activity: IC50 ~ 5.52
Action type: ANTAGONIST
Assay: Measured using a TR-FRET competitive displacement assay.
Drug: bexarotene
Target: Retinoic acid receptor RXR-alpha (Nuclear hormone receptor)
Gene: RXRA
UniProt: P19793 (RXRA_HUMAN)
Organism: Homo sapiens
Activity: Kd = 7.85
Action type: AGONIST
Assay: Inhibition of [3H]9-cis-RA binding to baculovirus expressed retinoid receptor RXR alpha
Drug: bexarotene
Target: Retinoic acid receptor RXR-beta (Nuclear hormone receptor)
Gene: RXRB
UniProt: P28702 (RXRB_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.23
Action type: AGONIST
Assay: Selective activity towards retinoid X receptor-beta
Drug: bexarotene
Target: Retinoic acid receptor RXR-gamma (Nuclear hormone receptor)
Gene: RXRG
UniProt: P48443 (RXRG_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.08
Action type: AGONIST
Assay: Selective activity towards retinoid X receptor-gamma
Drug: bexarotene
Target: Retinoic acid receptor beta (Nuclear hormone receptor)
Gene: RARB
UniProt: P10826 (RARB_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.3
Assay: Selective activity towards retinoic acid receptor-beta
Drug: bexarotene
Target: Retinoic acid receptor gamma (Nuclear hormone receptor)
Gene: RARG
UniProt: P13631 (RARG_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.89
Assay: Selective activity towards retinoic acid receptor-gamma
Drug: bexarotene
Target: Retinoic acid receptor RXR-beta (Transcription factor)
Gene: Rxrb
UniProt: P28704 (RXRB_MOUSE)
Organism: Mus musculus
Activity: Kd = 7.68
Assay: Binding affinity to Retinoic acid receptor RXR-beta was determined in a competitive binding assay.
Drug: bexarotene
Target: Retinoic acid receptor RXR-gamma (Transcription factor)
Gene: Rxrg
UniProt: P28705 (RXRG_MOUSE)
Organism: Mus musculus
Activity: Kd = 7.54
Assay: Binding affinity to Retinoic acid receptor RXR-gamma was evaluated in a competitive binding assay.
Drug: bexarotene
Target: Retinoic acid receptor RXR-alpha (Transcription factor)
Gene: Rxra
UniProt: P28700 (RXRA_MOUSE)
Organism: Mus musculus
Activity: EC50 = 7.4
Assay: Transactivation of Gal4-LBD fused mouse RXRalpha (218 to 467) transfected in african green monkey CV1 cells assessed as luciferase activity at after 6 hrs by Dual-light chemiluminescent assay
Drug: bexarotene
Target: Retinoic acid receptor RXR-alpha (Nuclear hormone receptor)
Gene: Rxra
UniProt: Q05343 (RXRA_RAT)
Organism: Rattus norvegicus
Activity: EC50 = 7.4
Assay: Agonist activity at RXRalpha in rat RK3E cells assessed as transcriptional activation by luciferase reporter gene assay
Drug: bexarotene
Target: Cytochrome P450 26A1 (Enzyme)
Gene: CYP26A1
UniProt: O43174 (CP26A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.87
Assay: Inhibition of microsomal fraction of human CYP26A1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addition measured after 1 min by HPLC analysis in presence of rat P450 reductase
Drug: bexarotene
Target: Cytochrome P450 26B1 (Enzyme)
Gene: CYP26B1
UniProt: Q9NR63 (CP26B_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.23
Assay: Inhibition of microsomal fraction of human CYP26B1 expressed in Sf9 cells using 9-cis-RA as substrate preincubated for 5 mins followed by NADPH addition measured after 5 mins by HPLC analysis in presence of rat P450 reductase
Drug: bexarotene
Target: Oxysterols receptor LXR-beta (Nuclear other)
Gene: NR1H2
UniProt: P55055 (NR1H2_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 6.36
Assay: Partial agonist activity at recombinant human GAL4-DBD-fused LXRbeta-LBD expressed in HEK293T cells measured after 12 to 14 hrs by dual-glo luciferase reporter gene assay
Drug: bexarotene
Target: Oxysterols receptor LXR-alpha (Nuclear other)
Gene: NR1H3
UniProt: Q13133 (NR1H3_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 6.71
Assay: Partial agonist activity at recombinant human GAL4-DBD-fused LXRalpha-LBD expressed in HEK293T cells measured after 12 to 14 hrs by dual-glo luciferase reporter gene assay
Drug: bezafibrate
Target: Lipoprotein lipase (Enzyme)
Gene: LPL
UniProt: P06858 (LIPL_HUMAN)
Organism: Homo sapiens
Drug: bezafibrate
Target: Peroxisome proliferator-activated receptor alpha (Nuclear hormone receptor)
Gene: PPARA
UniProt: Q07869 (PPARA_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 4.3
Action type: AGONIST
Drug: bezafibrate
Target: Peroxisome proliferator-activated receptor gamma (Nuclear hormone receptor)
Gene: PPARG
UniProt: P37231 (PPARG_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 4.178
Drug: bezafibrate
Target: Peroxisome proliferator-activated receptor delta (Nuclear hormone receptor)
Gene: PPARD
UniProt: Q03181 (PPARD_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 4.45
Assay: Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as activation of luciferase activity measured after 48 hrs by transactivation assay
Drug: bezafibrate
Target: Fatty acid-binding protein, intestinal (Cytosolic other)
Gene: FABP2
UniProt: P12104 (FABPI_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4.48
Assay: Displacement of 1-anilinonaphthalene-8-sulphonic acid from I-FABP
Drug: bezafibrate
Target: Fatty acid-binding protein, liver (Unclassified)
Gene: Fabp1
UniProt: P02692 (FABPL_RAT)
Organism: Rattus norvegicus
Activity: Ki = 4.35
Assay: Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP low binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay
Drug: bezafibrate
Target: 3-hydroxy-3-methylglutaryl-coenzyme A reductase (Enzyme)
Gene: HMGCR
UniProt: P04035 (HMDH_HUMAN)
Organism: Homo sapiens
Action type: INHIBITOR
Drug: biapenem
Target: Penicillin-binding protein 2 (Enzyme)
Gene: pbpA
UniProt: Q9X6V3 (Q9X6V3_PSEAI)
Organism: Pseudomonas aeruginosa
Drug: biapenem
Target: Penicillin-binding protein 4 (Enzyme)
UniProt: Q5D1E9 (Q5D1E9_STAAU)
Organism: Staphylococcus aureus
Drug: biapenem
Target: D-ala-D-ala-carboxypeptidase; D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase family protein; Penicillin-binding protein 5 (Enzyme)
Gene: dacA
UniProt: Q9X6V7 (Q9X6V7_PSEAI)
Organism: Pseudomonas aeruginosa
Drug: biapenem
Target: Penicillin-binding protein 1 (Enzyme)
Gene: ponA
UniProt: A1KS91 (A1KS91_NEIMF)
Organism: Neisseria meningitidis serogroup C / serotype 2a (strain ATCC 700532 / DSM 15464 / FAM18)
Drug: biapenem
Target: D-alanyl-D-alanine carboxypeptidase; D-alanyl-D-alanine carboxypeptidase penicillin-binding protein 6 (Enzyme)
Gene: dacC
UniProt: Q7CHG0 (Q7CHG0_YERPE)
Organism: Yersinia pestis
Drug: bicalutamide
Target: Androgen receptor (Nuclear hormone receptor)
Gene: AR
UniProt: P10275 (ANDR_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.72
Action type: ANTAGONIST
Assay: Inhibition of human AR
Drug: bicalutamide
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6
Assay: DRUGMATRIX: CYP450, 2C19 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: bicalutamide
Target: Androgen receptor (Transcription factor)
Gene: Ar
UniProt: P15207 (ANDR_RAT)
Organism: Rattus norvegicus
Activity: Ki = 7.85
Assay: Inhibition of rat AR
Drug: bicalutamide
Target: Androgen receptor (Transcription factor)
Gene: Ar
UniProt: P19091 (ANDR_MOUSE)
Organism: Mus musculus
Activity: IC50 = 6.17
Assay: Antiandrogen activity against androgen receptor in androgen-dependent mouse SC3 cells assessed as inhibition of testosterone-induced cell proliferation by WST1 assay
Drug: bicalutamide
Target: Progesterone receptor (Transcription factor)
Gene: PGR
UniProt: P06186 (PRGR_RABIT)
Organism: Oryctolagus cuniculus
Activity: IC50 = 5.25
Assay: Displacement of [3H]progesterone from rabbit PR by liquid scintillation counting
Drug: bicalutamide
Target: Progesterone receptor (Transcription factor)
Gene: Pgr
UniProt: Q63449 (PRGR_RAT)
Organism: Rattus norvegicus
Activity: Ki = 5.14
Assay: Inhibition of rat PR
Drug: bifemelane
Target: Lethal(3)malignant brain tumor-like protein 1 (Unclassified)
Gene: L3MBTL1
UniProt: Q9Y468 (LMBL1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.04
Assay: Inhibition of L3MBTL1 by alpha-screening
Drug: bifonazole
Target: Cytochrome P450 3A4 (Enzyme)
Gene: CYP3A4
UniProt: P08684 (CP3A4_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.1
Assay: In vitro CYP3A4 Inhibition Assay: Cytochrome P450 is a large and diverse group of enzymes that catalyze the oxidation of organic substances. Some members of the CYP family contribute to the elimination of ATRA by catalyzing its 4-hydroxylation in the mammalian liver and skin, including that of humans as well as swine. Applicant evaluated the potential RAMBA activity of several azoles using pig liver microsomes, a rich source of CYP activity, comprising many different CYP 450 isoforms. Therefore, this approach, while a reasonable way to assess CYP inhibitors with broad activities may or may not be the best way to discover RAMBAs with selectivity for the skin, which has a much more narrow complement of CYP expression. As understanding in this area has progressed, a more specific CYP inhibition assay can be used to provide better predictivity of activity in human skin. Nevertheless, this assay may still be used as a general predictor of overall CYP activity.
Drug: bifonazole
Target: Steroid 17-alpha-hydroxylase/17,20 lyase (Enzyme)
Gene: CYP17A1
UniProt: P05093 (CP17A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.25
Assay: In vitro inhibition of human Cytochrome P450 17A1 activity
Drug: bifonazole
Target: Lanosterol 14-alpha demethylase (Enzyme)
Gene: CYP51A1
UniProt: Q16850 (CP51A_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 6.47
Assay: Inhibition of human CYP51 expressed in Topp 3 cells by lanosterol demethylase assay
Drug: bifonazole
Target: Indoleamine 2,3-dioxygenase 1 (Enzyme)
Gene: IDO1
UniProt: P14902 (I23O1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.64
Drug: bimatoprost
Target: Aldo-keto reductase family 1 member C3 (Enzyme)
Gene: AKR1C3
UniProt: P42330 (AK1C3_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.3
Assay: Discontinuous Radiometric Assay: Compounds may be evaluated as selective reversible inhibitors of AKR1C3 by screening them against homogeneous recombinant AKR1C1-AKR1C4 expressed in E. coli. In each case, a discontinuous radiometric assay may be used to monitor the inhibition of progesterone reduction (20-ketosteroid reduction) catalyzed by AKR1C1, the inhibition of Δ4-AD reduction (17-ketosteroid reduction) catalyzed by AKR1C3, and the inhibition of 5α-DHT reduction (3-ketosteroid reduction) catalyzed by AKR1C2 and AKR1C4 (by measuring the formation of 20α-hydroxyprogesterone, testosterone or 3α-androstanediol by radiochromatography). Secondary screens of the compounds of interest include: (a) a full-screen against all nine human recombinant AKR enzymes to ensure there are no-intended off-target effects (in this context AKR1B10 (retinal reductase SEQ ID NO:5) has been shown to be potently inhibited by N-phenylanthranilates) (Endo et al., 2010, Biol. Pharm. Bull. 33:886-90) (
Drug: bimatoprost
Target: Prostaglandin F2-alpha receptor (GPCR)
Gene: PTGFR
UniProt: P43088 (PF2R_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.3
Action type: AGONIST
Drug: biotin
Target: Insulin-degrading enzyme (Enzyme)
Gene: IDE
UniProt: P14735 (IDE_HUMAN)
Organism: Homo sapiens
Activity: EC50 = 5.6
Assay: PUBCHEM_BIOASSAY: Counterscreen for IDE activators: Fluorescence polarization-based biochemical high throughput dose response assay for activators of recombinant IDE. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493087, AID493124, AID588439, AID588440, AID588442]
Drug: biperiden
Target: Muscarinic acetylcholine receptor M1 (GPCR)
Gene: CHRM1
UniProt: P11229 (ACM1_HUMAN)
Organism: Homo sapiens
Activity: Kd = 9.32
Action type: ANTAGONIST
Drug: biperiden
Target: Muscarinic acetylcholine receptor M2 (GPCR)
Gene: CHRM2
UniProt: P08172 (ACM2_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8.2
Action type: ANTAGONIST
Drug: biperiden
Target: Muscarinic acetylcholine receptor M3 (GPCR)
Gene: CHRM3
UniProt: P20309 (ACM3_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8.41
Action type: ANTAGONIST
Drug: biperiden
Target: Muscarinic acetylcholine receptor M4 (GPCR)
Gene: CHRM4
UniProt: P08173 (ACM4_HUMAN)
Organism: Homo sapiens
Activity: Kd = 8.62
Action type: ANTAGONIST
Drug: biperiden
Target: Muscarinic acetylcholine receptor M5 (GPCR)
Gene: CHRM5
UniProt: P08912 (ACM5_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.201
Drug: biperiden
Target: Neuronal acetylcholine receptor subunit alpha-2 (Ion channel)
Gene: CHRNA2
UniProt: Q15822 (ACHA2_HUMAN)
Organism: Homo sapiens
Drug: bisacodyl
Target: Sodium-dependent dopamine transporter (Transporter)
Gene: SLC6A3
UniProt: Q01959 (SC6A3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.756
Assay: DRUGMATRIX: Dopamine Transporter radioligand binding (ligand: [125I] RTI-55)
Drug: bisacodyl
Target: Kappa-type opioid receptor (GPCR)
Gene: OPRK1
UniProt: P41145 (OPRK_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.011
Assay: DRUGMATRIX: Opiate kappa (OP2, KOP) radioligand binding (ligand: [3H] Diprenorphine)
Drug: bisacodyl
Target: Cytochrome P450 2C9 (Enzyme)
Gene: CYP2C9
UniProt: P11712 (CP2C9_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5
Assay: DRUGMATRIX: CYP450, 2C9 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: bisantrene
Target: NAD(P)H dehydrogenase [quinone] 1 (Enzyme)
Gene: NQO1
UniProt: P15559 (NQO1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 4.6
Assay: Inhibition of human recombinant NQO1
Drug: bisoprolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.65
Action type: ANTAGONIST
Drug: bisoprolol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.94
Drug: bisoprolol
Target: Beta-3 adrenergic receptor (GPCR)
Gene: ADRB3
UniProt: P13945 (ADRB3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.04
Drug: bisoprolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: Adrb1
UniProt: P34971 (ADRB1_MOUSE)
Organism: Mus musculus
Activity: Ki = 8.28
Assay: Displacement of [3H]CGP12177 from mouse beta1 adrenoceptor expressed in HEK293T cell membranes
Drug: bisulepine
Target: Histamine H1 receptor (GPCR)
Gene: HRH1
UniProt: P35367 (HRH1_HUMAN)
Organism: Homo sapiens
Action type: ANTAGONIST
Assay: Mechanism of Action
Drug: bitolterol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Action type: AGONIST
Assay: Mechanism of Action; CHEMBL210; SINGLE PROTEIN
Drug: bivalirudin
Target: Prothrombin (Enzyme)
Gene: F2
UniProt: P00734 (THRB_HUMAN)
Organism: Homo sapiens
Activity: Ki = 8.6
Action type: INHIBITOR
Drug: blonanserin
Target: Sigma non-opioid intracellular receptor 1 (Membrane receptor)
Gene: SIGMAR1
UniProt: Q99720 (SGMR1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.54
Drug: blonanserin
Target: Alpha-1A adrenergic receptor (GPCR)
Gene: ADRA1A
UniProt: P35348 (ADA1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.25
Drug: blonanserin
Target: D(2) dopamine receptor (GPCR)
Gene: DRD2
UniProt: P14416 (DRD2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.854
Action type: ANTAGONIST
Drug: blonanserin
Target: 5-hydroxytryptamine receptor 2A (GPCR)
Gene: HTR2A
UniProt: P28223 (5HT2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.092
Action type: ANTAGONIST
Drug: bopindolol
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: HTR1A
UniProt: P08908 (5HT1A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.815
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT1A radioligand binding (ligand: [3H] 8-OH-DPAT)
Drug: bopindolol
Target: 5-hydroxytryptamine receptor 2A (GPCR)
Gene: HTR2A
UniProt: P28223 (5HT2A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.345
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2A radioligand binding (ligand: [3H] Ketanserin)
Drug: bopindolol
Target: 5-hydroxytryptamine receptor 2B (GPCR)
Gene: HTR2B
UniProt: P41595 (5HT2B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.014
Assay: DRUGMATRIX: Serotonin (5-Hydroxytryptamine) 5-HT2B radioligand binding (ligand: [3H] Lysergic acid diethylamide)
Drug: bopindolol
Target: Beta-3 adrenergic receptor (GPCR)
Gene: ADRB3
UniProt: P13945 (ADRB3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.463
Assay: DRUGMATRIX: Adrenergic beta3 radioligand binding (ligand: [125I] Cyanopindolol)
Drug: bopindolol
Target: Cytochrome P450 2D6 (Enzyme)
Gene: CYP2D6
UniProt: P10635 (CP2D6_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.262
Assay: DRUGMATRIX: CYP450, 2D6 enzyme inhibition (substrate: 3-Cyano-7-ethoxycoumarin)
Drug: bopindolol
Target: 5-hydroxytryptamine receptor 1A (GPCR)
Gene: Htr1a
UniProt: P19327 (5HT1A_RAT)
Organism: Rattus norvegicus
Activity: IC50 = 6.57
Drug: bopindolol
Target: Beta-1 adrenergic receptor (GPCR)
Gene: ADRB1
UniProt: P08588 (ADRB1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.51
Action type: ANTAGONIST
Drug: bopindolol
Target: Beta-2 adrenergic receptor (GPCR)
Gene: ADRB2
UniProt: P07550 (ADRB2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.65
Action type: ANTAGONIST
Drug: bortezomib
Target: Carbonic anhydrase 2 (Enzyme)
Gene: CA2
UniProt: P00918 (CAH2_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.94
Assay: Inhibition of human carbonic anhydrase-2 preincubated for 15 mins by stopped-flow CO2 hydration assay
Drug: bortezomib
Target: Carbonic anhydrase 1 (Enzyme)
Gene: CA1
UniProt: P00915 (CAH1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.89
Assay: Inhibition of human carbonic anhydrase-1 preincubated for 15 mins by stopped-flow CO2 hydration assay
Drug: bortezomib
Target: Carbonic anhydrase 4 (Enzyme)
Gene: CA4
UniProt: P22748 (CAH4_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.19
Assay: Inhibition of human CA4 by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Carbonic anhydrase 9 (Enzyme)
Gene: CA9
UniProt: Q16790 (CAH9_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.47
Assay: Inhibition of human CA9 by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Carbonic anhydrase 12 (Enzyme)
Gene: CA12
UniProt: O43570 (CAH12_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.23
Assay: Inhibition of human CA12 by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Prothrombin (Enzyme)
Gene: F2
UniProt: P00734 (THRB_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4.89
Assay: Inhibitory activity against thrombin
Drug: bortezomib
Target: Carbonic anhydrase 5A, mitochondrial (Enzyme)
Gene: CA5A
UniProt: P35218 (CAH5A_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.16
Assay: Inhibition of human CA5A by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Carbonic anhydrase 5B, mitochondrial (Enzyme)
Gene: CA5B
UniProt: Q9Y2D0 (CAH5B_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.17
Assay: Inhibition of human CA5B by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Carbonic anhydrase 7 (Enzyme)
Gene: CA7
UniProt: P43166 (CAH7_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.16
Assay: Inhibition of human CA7 by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Cytochrome P450 2C19 (Enzyme)
Gene: CYP2C19
UniProt: P33261 (CP2CJ_HUMAN)
Organism: Homo sapiens
Activity: Ki = 4.745
Drug: bortezomib
Target: 26S proteasome non-ATPase regulatory subunit 1 (Cytosolic other)
Gene: PSMD1
UniProt: Q99460 (PSMD1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 7.745
Drug: bortezomib
Target: Proteasome subunit alpha type-1 (Enzyme)
Gene: PSMA1
UniProt: P25786 (PSA1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 9.208
Action type: INHIBITOR
Drug: bortezomib
Target: Neutrophil elastase (Enzyme)
Gene: ELANE
UniProt: P08246 (ELNE_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.64
Assay: Inhibitory activity against human leukocyte elastase
Drug: bortezomib
Target: Carbonic anhydrase 3 (Enzyme)
Gene: CA3
UniProt: P07451 (CAH3_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.34
Assay: Inhibition of human CA3 by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Carbonic anhydrase 6 (Enzyme)
Gene: CA6
UniProt: P23280 (CAH6_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.36
Assay: Inhibition of human CA6 by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Cathepsin G (Enzyme)
Gene: CTSG
UniProt: P08311 (CATG_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.2
Assay: Inhibitory activity against human cathepsin G
Drug: bortezomib
Target: Carbonic anhydrase 14 (Enzyme)
Gene: CA14
UniProt: Q9ULX7 (CAH14_HUMAN)
Organism: Homo sapiens
Activity: Ki = 5.48
Assay: Inhibition of human CA14 by stopped-flow CO2 hydrase assay
Drug: bortezomib
Target: Chymase (Enzyme)
Gene: CMA1
UniProt: P23946 (CMA1_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 5.92
Assay: Inhibition of human chymase
Drug: bortezomib
Target: Chymotrypsinogen B (Enzyme)
Gene: CTRB1
UniProt: P17538 (CTRB1_HUMAN)
Organism: Homo sapiens
Activity: Ki = 6.49
Assay: Inhibitory activity against human Chymotrypsinogen
Drug: bortezomib
Target: Proteasome subunit beta type-8 (Enzyme)
Gene: PSMB8
UniProt: P28062 (PSB8_HUMAN)
Organism: Homo sapiens
Activity: IC50 = 8.09
Action type: INHIBITOR
Assay: Inhibition of chymotrypsin-like activity of LMP7 immunoproteasome by proteasome active site ELISA